Literature DB >> 17365656

Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipient.

Steven D Westbrook1, William R Kirkpatrick, Cesar O Freytes, Juan J Toro, Stella Bernardo, Thomas F Patterson, Spencer W Redding, Samuel A Lee.   

Abstract

Yeasts other than Candida albicans have emerged as important causes of fungal infection in hemopoietic stem cell transplant (HSCT) patients, particularly those receiving fluconazole prophylaxis. We report on an autologous hemopoietic stem cell transplant recipient who developed Candida krusei sepsis from pre-existing oral colonization.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17365656     DOI： 10.1080/13693780601164306

Source DB:  PubMed          Journal:  Med Mycol        ISSN： 1369-3786            Impact factor:   4.076


  9 in total

Review 1.  Oropharyngeal candidiasis in the era of antiretroviral therapy.

Authors:  George R Thompson; Payal K Patel; William R Kirkpatrick; Steven D Westbrook; Deborah Berg; Josh Erlandsen; Spencer W Redding; Thomas F Patterson
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-02-13

2.  Microbiology and epidemiology of oral yeast colonization in hemopoietic progenitor cell transplant recipients.

Authors:  Steven D Westbrook; William R Kirkpatrick; Nathan P Wiederhold; Cesar O Freytes; Juan J Toro; Thomas F Patterson; Spencer W Redding
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-01-09

3.  Occurrence of oral Candida colonization and its risk factors among patients with malignancies in China.

Authors:  Haiyan Sun; Yong Chen; Xuan Zou; Huan Li; Xiuyun Yin; Haifeng Qin; Rongrui Liu; Changlin Yu; Qihong Li; Kaitao Yu; Xuelin Han; Jingcai Zou; Cheng Ge; Li Han
Journal:  Clin Oral Investig       Date:  2015-07-30       Impact factor: 3.573

4.  Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.

Authors:  M A Pfaller; D J Diekema; D L Gibbs; V A Newell; E Nagy; S Dobiasova; M Rinaldi; R Barton; A Veselov
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

5.  Screening for drug-resistant Candida yeasts with chromogenic agar.

Authors:  William R Kirkpatrick; Joseph D Zimmerman; Fadi P Haikal; Michael J Broker; Erin Brockway; Annette W Fothergill; Dora I McCarthy; Thomas F Patterson; Spencer W Redding
Journal:  Med Mycol       Date:  2010-09       Impact factor: 4.076

6.  Integrated Analysis of Clinical and Microbiome Risk Factors Associated with the Development of Oral Candidiasis during Cancer Chemotherapy.

Authors:  Patricia I Diaz; Bo-Young Hong; Amanda K Dupuy; Linda Choquette; Angela Thompson; Andrew L Salner; Peter K Schauer; Upendra Hegde; Joseph A Burleson; Linda D Strausbaugh; Douglas E Peterson; Anna Dongari-Bagtzoglou
Journal:  J Fungi (Basel)       Date:  2019-06-13

Review 7.  Anti-Infective Antibody-Derived Peptides Active against Endogenous and Exogenous Fungi.

Authors:  Tecla Ciociola; Laura Giovati; Stefania Conti; Walter Magliani
Journal:  Microorganisms       Date:  2021-01-10

Review 8.  Roles for Structural Biology in the Discovery of Drugs and Agrochemicals Targeting Sterol 14α-Demethylases.

Authors:  Brian C Monk; Mikhail V Keniya
Journal:  J Fungi (Basel)       Date:  2021-01-20

9.  Characterization of the oral fungal microbiome (mycobiome) in healthy individuals.

Authors:  Mahmoud A Ghannoum; Richard J Jurevic; Pranab K Mukherjee; Fan Cui; Masoumeh Sikaroodi; Ammar Naqvi; Patrick M Gillevet
Journal:  PLoS Pathog       Date:  2010-01-08       Impact factor: 6.823
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.